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1. Introduction 
The chronic fatigue syndrome (CFS), which affects many young people in modern, stressful 
society, is an important health problem, characterized by persistent and relapsing, severe 
disabling fatigue, not resolved by rest, causing a marked reduction of working activity. 1-4 
Despite the public health burden imposed by CFS, effective diagnostic, treatment and 
prevention strategies are not available because the etiology, risk factors and 
pathophysiology remain unclarified. Various factors have been implicated in the genesis of 
CFS, including abnormal immune activation, chronic viral infection, impairment of central 
nervous system, exaggerated oxidative stress and current emotional disorders.1-8 Diagnosis 
of CFS can be made only after alternative known medical and psychiatric causes of chronic 
fatiguing illness have been excluded.1,3 
2. Chronic Fatigue Syndrome (CFS) and cardiac dysfunction or low  
cardiac output 
Cardiovascular dysfunction such as chronic heart failure, can be a main cause of disabling 
chronic fatigue and many symptoms seen in CFS patients are common in patients with low 
cardiac output syndrome. Indeed, accumulating evidence points to a possible problem with 
circulation in CFS. 9-14 The reported findings included autonomic dysfunction,15,16 lower 
plasma volume and/or red cell mass,17,18 and abnormalities in neurohumoral systems of 
circulatory control.19,20 In 2003 Peckerman et al.10 provided a preliminary indication of 
reduced cardiac output in patients with severe CFS. 
2.1 Small heart syndrome 
The concept that a heart small in relation to the body is inadequate for work was first stated 
by Laennec21 in 1826. Later Master22 reported several, so-called “neurocirculatory asthenia” 
cases with weakness or fatigue even after ordinary exertion, tachycardia, palpitation and 
dyspnea, who had a small heart shadow on chest radiography. The most frequent 
complaints are fatigue or weakness, rapid heart, precordial or chest pain, shortness of 
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breath, nervousness, trembling, sweating and fainting, many of them resembling those in 
CFS patients. Master hypothesized that these symptoms were caused by diminished venous 
return, diminished cardiac output, anoxemic heart muscle and decreased oxygen saturation 
of the blood due to congenital or constitutionally small heart. Similarly DaCosta23 described 
“irritable heart” in 1871, a peculiar form of functional disorder of the heart seen in the 
military population during the American Civil War. The disorder frequently presented 
either after an episode of diarrhea and persisted after the digestive disturbances had 
diminished, or originated suddenly without previous digestive disorder. Fatigue was an 
almost universal complaint in DaCosta’s syndrome, although symptoms includes 
palpitation, cardiac pain, headache, dimness of vision and giddiness.23,24 Diarrhea may lead 
to dehydration and reduce venous return or preload, resulting in further decreases in stroke 
volume and cardiac output in subjects with small heart.  
The apparent heart size or cardiothoracic ratio (CTR) is influenced by the position of the 
heart in the thoracic cage. A small heart may be due to a standing or dropped heart 
resulting from a low diaphragm and a narrow chest in association with a thin physique 
and low fat content in epicardial and pericardial spaces. Consequently, the 
pathognomonic significance of small heart has not been established and is now being 
overlooked or even ignored.25 
In order to clarify the pathophysiological significance of small heart syndrome as a 
cardiovascular disease, we studied 47 patients (16 men and 31 women, mean age: 29±6 
years) with a small heart shadow (CTR ≤42% on a chest roentgenogram) and without 
significant systemic disease who consecutively visited our clinic with possible 
cardiovascular symptoms, as well as 24 controls (C). These patients with small heart 
syndrome were divided into 2 groups, 25 patients with severe symptoms (S) and 22 patients 
with mild ones (M), according to the presence or absence of cardiovascular symptoms 
including general malaise, easy fatigability, fainting, dizziness, weakness, chest pain, 
dyspnea and palpitations that were sufficiently severe to significantly disturb their 
occupational, educational, social or personal activities. Figures 1 and 2 show the chest X 
roentgenograms of typical cases of group S. 
All individuals underwent standard M-mode and two-dimensional echocardiography. 
The left ventricular (LV) dimensions were measured according to the recommendations 
of the American Society of Echocardiography.26 LV volume was calculated by the 
Teichholz’ formura,27 and an ejection feaction was obtained by the conventional 
method. 
Results are summarized in Tables 1 and 2 and Figures 3-6. As shown in Table 1, the 
symptom of general malaise and/or easy fatigability was significantly more frequent in S 
than in M (88% vs. 50%, p<0.05). In addition, symptoms including orthostatic dizziness, 
shortness of breath, dyspnea on effort, palpitations, fainting and chest pain were more 
frequent in S than in M, although no significant difference was found. In addition, physical 
findings including narrow chest, foot coldness, pretibial pitting edema, bimanual right 
kidney palpability, epigastric splash sound, mid-systolic click, late systolic murmur and 
hypotension were more frequently noted in S than in M, although no significant difference 
was found. 
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Fig. 1. Chest roentgenogram of a 38-year-old male patient with small heart syndrome 
(cardiothoracic ratio: 28%) in which vertebral scoliosis was also noted. From about 15 years ago, 
the patient suffered from severe general malaise, easy fatigability, dyspnea on effort, palpitations 
and chest pain. He also occasionally developed severe dyspnea with hyperventilation, trembling, 
sweating and sleep disturbance. He found that upon obtaining employment, he could not work 
as expected. Upon consulting a psychiatrist 10 years ago, he was diagnosed with anxiety neurosis 
and treated with medication. He subsequently developed alcoholism. He frequently visited 
emergency outclinics due to severe dyspnea and anxiety. 
38M 
Cardiothoracic ratio: 28% 
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Fig. 2. Chest roentgenogram of a 24-year-old female patient with small heart syndrome 
(cardiothoracic ratio: 32%). For about 7 years, the patient suffered from severe general fatigue, 
fainting and orthostatic dizziness. She also frequently developed a headache, chest pain and a 
sore throat. She was frequently unable to work as a dietician due to increasingly impaired short-
term memory and concentration. 
24F 
Cardiothoracic ratio: 32% 
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 Small heart syndrome 
 Mild (M) p value Severe (S) 
Number of patients 22  25 
Sex (male/female) 7/15  8/17 
Age (years) 30±7 NS 28±6 
Symptoms    
General malaise 10 (45%) NS 18 (72%) 
Easy fatigability 7 (32%) NS 14 (56%) 
General malaise and/or easy fatigability 11 (50%) <0.05 22 (88%) 
Orthostatic dizziness 8 (36%) NS 11 (44%) 
Shortness of breath 4 (18%) NS 7 (28%) 
Dyspnea on effort 5 (23%) NS 9 (36%) 
Palpitations 5 (23%) NS 7 (28%) 
Faintng 5 (23%) NS 9 (36%) 
Chest pain 7 (32%) NS 10 (40%) 
Physical findings    
Narrow chest 11 (50%) NS 18 (72%) 
Foot coldness 8 (36%) NS 16 (64%) 
Pretibial pitting edema 5 (23%) NS 9 (36%) 
Right kidney palpability 9 (41%) NS 14 (56%) 
Epigastric splash sound 3 (14%) NS 6 (24%) 
Mid-systolic click 2 ( 9%) NS 3 (12%) 
Late systolic murmur 4 (18%) NS 5 (20%) 
Hypotension (SBP <100 mmHg) 5 (23%) NS 8 (32%) 
M: patients with small heart syndrome and mild symptoms, S: patients with small heart syndrome and 
severe symptoms, NS: not significant, SBP: systolic blood pressure 
 
 
Table 1. Comparison of the prevalence of symptoms and physical findings between the 
study groups with mild or severe symptoms 
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Fig. 3. Comparison of the left ventricular end-diastolic dimension (LVEDD) among the 
study groups. The mean LVEDD was significantly smaller in S (patients with small heart 
syndrome and severe symptoms) than in M (patients with small heart syndrome and mild 
symptoms) and C (control subjects). It was also significantly smaller in M than in C. 
 
Fig. 4. Comparison of the left ventricular end-diastolic dimension/body surface area 
(LVEDD/BSA) among the study groups. The mean LVEDD/BSA was significantly lower in 
S (patients with small heart syndrome and severe symptoms) than in M (patients with small 
heart syndrome and mild symptoms) and C (control subjects). No significant difference was 
found between M and C. 
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Fig. 5. Comparison of the stroke volume index among the study groups. The mean stroke 
volume index was significantly lower in S (patients with small heart syndrome and severe 
symptoms) than in M (patients with small heart syndrome and mild symptoms) and C 
(control subjects). No significant difference was found between M and C. 
 
 
Fig. 6. Comparison of the cardiac index among the study groups. The mean cardiac index 
was significantly lower in S (patients with small heart syndrome and severe symptoms) than 
in M (patients with small heart syndrome and mild symptoms) and C (control subjects). No 
significant difference was found between M and C. 
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 Control (C)  Small heart syndrome 
   Mild (M)  Severe (S) 
  p value  p value  
Number of patients 24  22  25 
Sex (male/female) 8/16  7/15  8/17 
Age (years) 32±8 NS 30±7 NS 28±6 
Body height (cm) 161±9 NS 163±8 NS 163±9 
Body weight (kg) 63±17 <0.01 52±10 NS 50±10* 
Body mass index (kg/m2) 24±5 <0.001 19±2 NS 18±2† 
Body surface area (m2) 1.67±0.24 NS 1.56±0.17 NS 1.53±0.17‡ 
Cardiothoracic ratio (%) 45±2 <0.001 40±3 NS 38±4† 
Heart rate (beats/min) 70±11 NS 71±12 NS 68±11 
IVST (mm) 8.8±1.2 NS 8.4±0.9 NS 8.3±1.4 
LVPWT (mm) 9.0±1.0 <0.01 8.2±1.1 NS 7.9±1.3* 
LVEDD (mm) 46±5 <0.05 43±2 <0.001 39±4† 
LVEDD/BSA (mm/m2) 28±2 NS 28±3 <0.05 26±3* 
LVESD (mm) 28±3 NS 26±3 NS 25±4† 
LVESD/BSA (mm/m2) 17±2 NS 17±2 NS 16±3 
LAD (mm) 28±5 NS 25±3 NS 25±4 
AoD (mm) 27±4 NS 25±3 NS 25±3 
RVD (mm) 15±4 NS 16±3 NS 16±4 
Stroke volume (mL) 68±16 <0.001 58±9 <0.001 46±12† 
Stroke volume index (mL/m2) 40±6 NS 37±6 <0.001 30±7† 
Cardiac output (L/min) 4.7±1.2 <0.05 4.0±0.6 <0.001 3.1±0.8† 
Cardiac index (L/min/m2) 2.8±0.6 NS 2.6±0.5 <0.001 2.0±0.4† 
Cardiac index <2 L/min/m2 1 (4%) NS 2 (9%) <0.01 15 (60%)* 
Fractional shortening (%) 39±3 NS 38±5 NS 37±5 
Ejection fraction (%) 69±4 NS 69±6 NS 68±6 
Mitral valve prolapse 0 (0%) NS 3 (14%) NS 4 (16%) 
M: patients with small heart syndrome and mild symptoms, S: patients with small heart syndrome and 
severe symptoms, IVST: interventricular septum thickness, LVPWT: left ventricular posterior wall 
thickness, LVEDD: left ventricular end-diastolic dimension, LVESD: left ventricular end-systolic 
dimension, LAD: left atrial dimension, AoD: aortic root diameter, RVD: right ventricular dimension, 
NS: not significant, *: p<0.01 vs. C, †: p<0.001 vs. C, ‡: p<0.05 vs. C 
Table 2. Comparison of the echocardiographic findings among study groups 
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As shown in Table 2, both the mean body weight and body mass index were significantly 
lower in both S and M than in C, although the mean body height was not significantly 
different among the study groups. The mean body surface area was also significantly 
(p<0.05) smaller in S than in C, although the difference was not significant between M and 
C. The mean CTR (%) values were in the order of S (38±4) < M (40±3) < C (45±2). CTR was 
significantly (p<0.001) lower in S and M than in C, although no significant difference was 
noted between S and M. 
The results of the echocardiographic examination are shown in Table 2 and Figures 3-6. The 
LV posterior wall (mm) was significantly (p<0.01) thinner in S (7.9±1.3) and M (8.2±1.1) than 
in C (9.0±1.0), although interventricular septum thickness was not significantly different 
among the groups. The mean LV end-diastolic dimension (LVEDD) (mm) values were in the 
order of S (39±4) < M (43±2) < C (46±5) (Figure 3). LVEDD was significantly smaller in S 
(p<0.001) and larger in C (p<0.05) than in M. The mean LVEDD/body surface area 
(mm/m2) was significantly smaller in S (26±3) than in M (28±3, p<0.05) and C (28±2, p<0.01) 
(Figure 4). No significant difference was noted in the mean value of LVEDD/body surface 
area between M and C. In addition, the mean LV end-systolic dimension (LVESD) (mm) 
values were in the order of S (25±4) < M (26±3) < C (28±3). LVESD was significantly 
(p<0.001) smaller in S than in C. The mean LVESD/body surface area (mm/m2) was not 
significantly different among S (16±3), M (17±2) and C (17±2). 
Both mean stroke volume and cardiac output values were in the order of S < M < C. Both 
values were significantly smaller in S and larger in C than in M. The mean stroke volume 
index (mL/m2) was significantly (p<0.001) smaller in S (30±7) than in M (37±6) and C (40±6) 
(Figure 5). The mean cardiac index (L/min/m2) was significantly (p<0.001) smaller in S 
(2.0±0.4) than in M (2.6±0.5) and in C (2.8±0.6) (Figure 6). No significant difference was 
noted in the mean value of stroke volume index or cardiac index between M and C. The 
prevalence of low cardiac index (<2 L/min/m2) was significantly (p<0.01) higher in S (60%) 
than in M (9%) and C (4%). LV ejection fraction (%) was quite comparable among S (68±6), 
M (69±6) and C (69±4). Mitral valve prolapse was diagnosed in some of the subjects in S 
(16%) and M (14%). 
Thus, we concluded that in patients with a small heart shadow on a chest roentgenogram, a 
small LV size was generally associated with low cardiac output, which was particularly  
 
Fig. 7. Characterization of the patients with small heart syndrome. 
Small heart syndrome 
 postulated by Master in 1944 
1) Small heart shadow on chest roentgenogram  
2) Hypotension and/or orthostatic dysregulation 
3) General malaise, easy fatigability, dizziness, palpitation, dyspnea, chest pain, 
headedness and cold feet 
4) No organic heart disease or systemic disease  
5) Thin physiques, asthenia, visceroptosis and wandering kidney 
6) Straight back and flat chest 
7) Often complicated with mitral valve prolapse syndrome 
8) Young female dominant 
9) Naïve, delicate and serious character 
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Fig. 8. A typical “straight back” observed in a lateral view chest roentgenogram obtained 
from a 18-year-old female patient with small heart syndrome. 
marked in the patients with severe symptoms and therefore, the pathognomonic 
significance of a small heart should be recognized as a constitutional factor that predisposes 
individuals to low output syndrome.28 
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Patients with small heart syndrome are known to have slender structures with low body 
mass indexes, frequently visceral ptosis with wandering kidney, asthenia, nervousness as 
well as foot coldness, suggesting physical, autonomic nervous and psychological irritability 
or lack of relaxation (Figure 7).11,22,28,29 Thoracic skeletal abnormalities such as shallow chest, 
straight thoracic spine or loss of the physiologic thoracic kyphosis (Figure 8), and scoliosis 
are frequently noted in the patients.11,22,30-32 Mitral valve prolapse33,34 associated with 
symptoms such as chest pain, palpitation and dyspnea is a frequent complication of patients 
with small heart syndrome.11,22,24,30-32 Many of the small heart subjects appeared to be 
emotionally sensitive, often delicate and nervous. These conditions may be genetically 
determined, although several other factors may also be involved in the constitution.22 
In order to work and perform other duties without excessive exhaustion patients with small 
heart syndrome need to have enough rest and both physical and emotional relaxation.11,12 
Various triggers including loss of appetite, diarrhea and summer sweating can cause 
dehydration resulting in preload reduction. It is possible that further reductions in cardiac 
performance due to preload reduction play an important role in predisposing subjects with 
small hearts to symptoms including general malaise, fatigue, dizziness, orthostatic 
dysregulation, dyspnea on effort and palpitations. Autonomic nervous dysfunction with 
possible accentuated basal parasympathetic tone may be associated with these symptoms 
through the inhibition of sympathetic activation, which is required to preserve proper 
cardiac function.13 Habitual exercise, which can facilitate autonomic nervous adaptation and 
induce pulmonary and cardiovascular conditioning, may improve the functional work 
capacity and fatigue by increasing cardiac output. Diarrhea, sweating and loss of appetite as 
triggering factors for exacerbation should be avoided or treated properly. Constitutional 
change or conversion is not easy. They may need to take holidays occasionally. And people 
in their work place and society should understand their specific needs. 
2.2 Small heart syndrome as an unrecognized cause of CFS 
Recently it has been reported that chest roentgenographic, electrocardiographic and, 
echocardiographic examinations revealed several distinct findings in CFS patients.11-13 
Specifically, a small heart shadow was often observed on the chest roentgenogram in these 
patients. In 2008 we first reported that “small heart” with low cardiac output demonstrated 
by both roentgenographically and echocardiography is prevalent in CFS patients.11 In this 
report. small heart syndrome (CTR ≤42%) was significantly more prevalent in the CFS group 
(n=56) (61%) than in the control group (n=38) (24%) (Table 3). In CFS patients with a small 
heart (n=34), narrow chest (88%), orthostatic dizziness (44%), foot coldness (41%), pretibial 
pitting edema (32%), r-kidney palpability (47%), and mitral valve prorapse (29%) were all 
significantly more prevalent than in the control group, and also in the CFS patients without 
small heart syndrome (Table 4). Echocardiographic examination demonstrated significantly 
smaller values of both LV end-diastolic and end-systolic dimensions, and stroke volume and 
cardiac indexes in CFS with a small heart as compared with control subjects with a normal 
heart size (42%< CTR <50%) (Table 5). Thus, a considerable number of CFS patients have a 
small heart and cardiac performance is actually impaired with low cardiac output due to a 
small LV chamber size and poor cardiac function with low stroke volume and cardiac 
indexes in many of CFS patients.11 In addition, both the reduced cardiac size and 
performance during the exacerbation phase was improved during the remission phase in 
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CFS patients with “small heart”, suggesting that small heart syndrome with impaired 
cardiac function may play an important role in the genesis of CFS (Table 6).12 Also 
cardiothoracic ratios increased significantly during the remission phase as compared with 
exacerbation phase (Table 6).12 Reduced LV ejection fraction was not observed in any 
patients, suggesting no myocardial systolic dysfunction. Many CFS patients have low 
cardiac output and the resulting low flow circulatory state may make it difficult for patients 
to meet the demands of everyday activity, and it may also lead to fatigue and other 
conditions. Small heart syndrome may contribute to the development of CFS as a 
constitutional factor predisposing to fatigue, and may be included in the genesis of CFS. 
 
 Control    CFS     p 
n  38 56 
Gender (male/female) 19/19  26/30  NS  
Age (year)  36±8  33±8  NS  
Body mass index  22±3  21±5  NS  
CTR (%)        
    ≤42   9 (24%)  34 (61%)  p<0.01  
    ≤40   6 (16%)  25 (45%)  p<0.01  
Narrow chest  7 (18%)  33 (59%)  p<0.01  
CFS: Chronic fatigue syndrome; CTR: cardiothoracic ratio; NS: not significant  
Table 3. Comparison of chest roentgenographic and physical examination findings in study 
patients 
 
    Control  CFS    
          Small heart  
                   (-)       (+)   p value  
n   38  22   34  
Male/female  19/19  13/9   13/21      
Age (year)  36±8   34±8   31±8     <0.05*  
Body mass index  22±3  25±6   19±3    <0.001*  
Narrow chest  7 (18%)  4 (18%)    30 (88%) <0.01*  
Orthostatic dizziness  5 (13%)   3 (14%)     15 (44%) <0.05*  
Foot coldness       4 (11%)   2 ( 9%)    14 (41%) <0.05*  
Pretibial pitting edema  3 ( 8%)   1 ( 5%)   11 (32%)  <0.05*  
r-kidney palpability  4 (11%)  1( 5%)      1 (47%)  <0.01* 
Mitral valve prolapse  3 ( 8%)  0 ( 0%)    10 (29%)  <0.05*  
*: vs. Control and Small heart (-) 
CFS: Chronic fatigue syndrome 
Table 4. Comparison of physical examination findings in control and CFS, with and without 
a small heart 
Indeed, CFS patients had a variety of possible cardiovascular complaints, including chest 
pain, palpitation, dyspnea or shortness of breath, coldness of feet, dizziness and fainting, 
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although all of these symptoms are not necessarily attributable to cardiovascular 
dysfunction.13 Frequently noted physical examination findings such as epigastric splash 
sound, right kidney palpability, cold feet and pretibial pitting edema, may be related to 
visceral ptosis with slender build, and peripheral circulatory impairment.13 Weakness, rapid 
heartbeat and orthostatic dizziness may be related to hypotension and orthostatic 
dysregulation. Auscultatory findings including a late systolic murmur and a mid-systolic 
click suggested typical mitral valve prolapse in some of the patients. In addition, 
electrocardiograms showed severe sinus arrhythmia and vertical or right axis deviation in a 
considerable number of the patients, suggesting parasympathetic predominance and 
vertical heart position.13 Following our reports Hurwitz et al.14 reported that severe CFS 
patients had lower cardiac output associated with lower cardiac volume indicated 
echocardiographically and lower total blood volume, plasma volume and red blood cell 
volume indicated by dual tag blood volume assessments as compared with controls, 
suggesting a co-morbid hypovolemic condition. 
 
              Control              CFS  
      with small heart  
        50%>CTR>42%  CTR<42%  p value  
n    30  34  
Male/female   11/19     13/21    NS  
Age (y)     34±13   31±8    0.219  
Body height (cm)   163±7   164±10  0.451  
Body weight (kg)   60±16   53±11  0.040*  
Body surface area (m2)  1.6±0.2   1.6±0.2  0.146 
Heart rate (beats/min)  69±12  72±13  0.363  
IVS (mm)   9±1   9±1  0.574  
PW (mm)   9±1   8±1  0.709  
LVEDD (mm)   45±4  41±5  0.002* 
LVESD (mm)     28±3  25±5   0.038*  
LAD (mm)   27±5  25±4  0.229  
AoD (mm)    27±5  26±4  0.261  
RAD (mm)   15±3  16±4  0.361  
Stroke volume (ml)  65±14  52±14  0.001* 
Stroke volume index (ml/m2) 39±7  33±8    0.001* 
Cardiac output (l/min)   4.4±1.2   3.7±1.0  0.005*  
Cardiac index (l/min/m2)   2.7±0.6   2.3±0.6      0.012*  
Fractional shortening (%)   39±4  37±4  0.188 
Ejection fraction (%)  69±4  68±5  0.313  
*: significant 
IVS: interventrricular septum thickness; PW: LV posterior wall thickness; EDD: end-diastolic 
dimension; ESD: end-systolic dimension; LAD: left atrial dimension; AoD: aortic root diameter; RVD; 
right ventricular dimension 
CFS: chronic fatigue syndrome 
Table 5. Comparison of echocardiographic findings in control with a normal heart size and 
CFS with a small heart 
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   Exacerbatioin         Remission p value 
Heart rate (beats/min)  71±9  63±6 0.014* 
LVEDD (mm)   38±4  43±3 <0.001* 
LVESD (mm)   24±2  27±2 0.015* 
Stroke volume (ml)  41±10  56±11 <0.001* 
Stroke volume index (ml/m2) 28±7  39±6 <0.001* 
Cardiac output (l/min)  2.8±0.6  3.6±0.9 0.017* 
Cardiac index (l/min/ m2)  2.0±0.4  2.5±0.5 0.014* 
Ejection Fraction (%)  66±3  68±6 0.443 
CTR (%)    38±2  40±2      <0.001* 
LV: left ventricular; EDD: end-diastolic dimension; ESD: end-systolic dimension; CTR: cardiothoracic 
ratio 
*: statistically significant 
Table 6. Comparison of echocardiographic findings of 10 CFS patients with a small heart 
between the exacerbation and remission phases 
3. Orthostatic Intolerance (OI) 
Patients with orthostatic intolerance have been clinically recognized.35-37 The patients 
predictably develop symptoms of disabling fatigue, dizziness, diminished concentration, 
tremulousness, and nausea while standing (Table 7). Simple activities such as eating, 
showering, or low intensity exercise may profoundly exacerbate these symptoms. Reduced 
cerebral blood flow with impaired cerebral oxygenation during an upright posture is 
considered as major mechanism for orthostatic intolerance,17,38 although compensatory 
sympathetic activation also seems to play an important role in the development of the  
Symptoms While Standing in Patients with Orthostatic Intolerance 
Disabling fatigue 
General malaise 
Diminished concentration 
Dizziness 
Fainting 
Pallolr 
Weakness 
Tremulousness 
Sweating 
Light headedness 
Visual disturbance 
Palpitations 
Dyspnea 
Nausea 
Nervousness 
Table 7. Symptoms while standing in patients with orthostatic intolerance 
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various symptoms in cases it is exaggerated.36-41 Assuming an upright posture causes 
translocation of approximately 800 ml of blood from the intrathoracic venous compartment 
to veins of the buttocks, pelvis and legs.42 The normal compensatory cardiovascular 
response to this orthostatic stress is a neurogenically mediated increase in heart rate and in 
systemic vascular resistance.42 Not all vascular beds contribute equally to the reflex increase 
in vascular resistance.42 Splanchnic vasoconstriction accounts for one third, and skin and 
muscle vasoconstriction, approximately 40% of the increased vascular resistance during 
normal levels orthostatic stress.42 Symptoms of orthostatic intolerance develop as these 
reflexes approach the limit of compensation. 
3.1 Similarities and overlaps between CFS and OI 
Many of the primary symptoms of orthostatic intolerance are often seen in patients with 
disabling CFS.17,42,43 Both CFS and orthostatic intolerance affects many young people, 
predominantly women. Many symptoms of OI appear to be related to reduced cerebral 
blood flow. Symptoms are associated with inadequate systemic venous return to the right 
heart or thoracic hypovolemia,35,36 although precise mechanisms remain to be clarified. Also 
excessive lower body venous pooling with delayed orthostatic hypotension, by reducing 
cerebral perfusion, has been suggested to be involved in the orthostatic component of 
fatigue in CFS patients.44 
3.2 Pathopysiology of OI 
Potential pathophysiological mechanisms in chronic orthostatic intolerance include a β-
adrenergic hypersensitivity,45 decreased plasma volume,46 an inappropriate venous 
pooling,44 and possible dysautonomia.36-41,47 Several disorders including delayed orthostatic 
hypotension,17 neurally mediated hypotension48 and postural orthostatic tachycardia 
syndrome35-38 underlies or promotes orthostatic intolerance. Delayed orthostatic 
hypotension can be caused by excessive gravitational venous pooling.17,44 Impaired 
vasoconstrictor function with relative bradycardia is often seen in neurally mediated 
hypotension.48 In 1995 Rowe et al.48 described the cases with an overlap in the symptoms of 
CFS and neurally mediated hypotension, suggesting that neurally mediated hypotension 
should be considered as a treatable cause of CFS. Exaggerated tachycardia and 
vasoconstriction without hypotension of postural orthostatic tachycardia syndrome (POTS) 
during standing can cause orthostatic intolerance,35-38 although pathophysiology of POTS 
remains unclear. In 1982 Rosen and Cryer were the first to describe a woman with a 7-year 
history of disabling postural tachycardia and palpitations in association with an idiopathic 
reduction in plasma volume.35 In 1993 Schondorf and Low36 reviewed the patients who 
exhibited exaggerated tachycardia at rest or during head-up tilt and named “idiopathic 
postural orthostatic tachycardia syndrome” which may be a manifestation of a mild form of 
acute autonomic neuropathy. Studies suggest that POTS is accompanied with a range of 
autonomic nervous system abnormalities including vagal withdrawal and enhanced 
sympathetic modulation, associated with findings consistent with pooling in the lower 
limbs.36-41,44,47 Also studies in adolescents suggest that POTS physiology underlies OI in the 
majority of CFS patients.41-44 POTS is a frequent finding in patients with CFS.41-44 Clinical 
evaluation of CFS patients should include response to standing. POTS may be an under-
recognized condition in CFS as Hoad et al.49 recently suggested. 
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3.3 OI and small heart 
Recently it has been reported that patients with postural orthostatic tachycardia, which is 
often noted in patients with chronic orthostatic intolerance, had a smaller heart coupled 
with reduced blood volume compared with healthy controls.50 By using a cardiac magnetic 
resonance imaging technique, Fu et al.50 assessed precisely the heart size and mass in POTS 
patients and found that cardiac size and mass and blood volume were much smaller in the 
patients compared with healthy sedentary controls. The marked orthostatic tachycardia in 
these patients seemed to be a physiologic compensatory response to a smaller stroke volume 
and exercise training improved this syndrome in most patients.50 Fu et al.50 offered POTS a 
new name based on its underlying pathophysiology, the “Grinch syndrome”, because in this 
famous children’s book by Dr Seuss, the main character had a heart that was “two sizes too 
small”. In their assessment of both sympathetic baroreflex sensitivity and cardiovagal 
baroreflex sensitivity, the function of autonomic nervous system was intact in the patients,50 
although other researchers have postulated autonomic nervous dysfunction with 
exaggerated sympathetic nervous activation over compensatory levels during standing as a 
major mechanism for the symptoms.35,36,40,41,47 
Although some dysautonomia cause orthostatic instability accompanied with abnormal 
changes in heart rate and blood pressure, whether disorders of the autonomic nervous 
system is responsible for OI and also OI in CFS patients is controversial.38,39,43,44,50 Recently, 
Jones et al.51 reported that orthostatic instability was similar in persons with CFS and 
nonfatigued control subjects recruited from the general Wichita population. Interestingly 
persons with higher serum osmolarity levels had significantly higher abnormal tilt rates 
than those with lower serum osmolarity levels, suggesting that delayed responses to head-
up tilt tests may reflect hydration status.51 Reappraisal of primary dysautomia as a factor in 
the pathogenesis of CFS and also OI may be needed. In the meanwhile Ewan et al.52 
reported that use of the sinus node blocker ivabradine led to dramatic improvements in 
subjective and objective symptomatology in line with a reduction in heart rate on standing 
in a 21 year-old female patient with POTS. Use of this medication appears to not only 
improve tachycardia but also symptomatology, including fatigue, suggesting that 
tachycardia is not only unnecessary for maintaining cerebral perfusion while standing as a 
compensatory mechanism but also triggers many symptoms possibly through disturbances 
in autonomic nervous system. 
3.4 Pronounced small heart in CFS with OI 
We aimed to test a hypothesis that small heart is associated with OI in patients with CFS. 
Among the 46 study CFS patients, 26 (57%) were classified as CFSOI according to the presence 
of OI. In addition, 11 OI patients and 27 age- and sex-matched control subjects (Controls)  
were studied. Left ventricular (LV) dimensions and function were determined 
echocardiographically. As shown in Table 8 and Figures 9-11, the mean values of 
cardiothoracic ratio, systemic systolic and diastolic pressures, LV end-diastolic dimensions, LV 
end-systolic dimensions, stroke volume indexes, cardiac indexes and LV mass indexes were all 
significantly smaller in CFSOI and OI than in Controls. A smaller LV end-diastolic dimension 
(< 40 mm) was significantly more prevalently noted in CFSOI (54%) and OI (45%) than in 
Controls (4%). A lower cardiac index (< 2 l/min/mm2) was more prevalent in CFSOI (65%) 
than in OI (27%) and Controls (11%). The mean values of both LV fractional shortening and 
ejection fraction were comparable among the groups (Table 8). In conclusion, a small size of 
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LV with low cardiac output was noted in OI and marked in CFSOI. A small heart appears to 
be related to the genesis of OI and CFS via both cerebral and systemic hypoperfusion. CFSOI 
seems to constitute a well-defined and predominant subgroup of CFS. 
 
CFSOI: patients with chronic fatigue syndrome and orthostatic intolerance 
OI: patients with orthostatic intolerance but without chronic fatigue syndrome 
Controls: healthy control subjects 
Fig. 9. Comparison of the left ventricular end-diastolic dimensions (LVEDD) among the 
study groups. 
 
CFSOI: patients with chronic fatigue syndrome and orthostatic intolerance 
OI: patients with orthostatic intolerance but without chronic fatigue syndrome 
Controls: healthy control subjects 
Fig. 10. Comparison of the stroke volume indexes among the study groups. 
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CFSOI: patients with chronic fatigue syndrome and orthostatic intolerance 
OI: patients with orthostatic intolerance but without chronic fatigue syndrome 
Controls: healthy control subjects 
 
 
 
Fig. 11. Comparison of the cardiac indexes among the study groups. 
Elucidation of the pathophysiology of CFS and OI may lead to better therapeutic strategies. 
Recently, xenon-computed tomography blood flow studies demonstrated that CFS patients 
have global cerebral hypoperfusion with reduced absolute cortical blood flow in broad 
areas, especially in bilateral middle cerebral artery territories, compared with healthy 
controls.53 Impaired cerebral oxygenation due to reduced cerebral hemodynamics in young 
CFS with OI during an active standing test was suggested from the findings of continuous 
measurement of cerebral oxygenated hemoglobin using near-infrared spectroscopy.54 In the 
present study, low systolic and diastolic blood pressures were noted in OI patients with and 
without CFS compared with those in control subjects. Newton et al.55 have consolidated the 
evidence using 24-hour ambulatory blood pressure monitoring that lower blood pressure 
occurs in CFS patients and lower nighttime blood pressure seems to be a significant problem 
that may lead to the enhanced diurnal variation. The putative mechanism by which OI and 
CFS are triggered or caused in patients with a small heart is shown in Figure 12. 
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 CFSOI OI Controls 
Number of patients 26 11 27 
Male/Female 7/19 2/9 10/17 
Age (years) 28±8 31±7 32±7 
Cardiothoracic ratio (%) 38±5† 42±3‡ 44±4 
Heart rate (beats/min) 69±15 68±11 70±12 
Systolic blood pressure (mmHg) 109±11* 112±14† 121±11 
Diastolic blood pressure (mmHg) 66±12* 68±13† 75±12 
IVS (mm) 8±1 8±1 9±1 
PW (mm) 8±1 8±1 9±1 
LVEDD (mm) 39±5* 40±5* 45±4 
<40 14 (54%)* 5 (45%)* 1 (4%) 
LVESD (mm) 25±5* 24±5* 27±2 
LAD (mm) 25±5 24±4 27±4 
AoD (mm) 26±4 25±3 27±5 
RVD (mm) 15±4 15±2 15±3 
Stroke volume (ml) 45±13* 49±11* 63±13 
Stroke volume index (ml/m2) 30±7* 33±7† 39±7 
Cardiac output (l/min) 3.0±0.7* 3.3±1.0* 4.4±1.0 
Cardiac index (l/min/m2) 2.0±0.3*† 2.2±0.5† 2.7±0.6 
< 2 17 (65%)* 3 (27%) 3 (11%) 
Fractional shortening (%) 37±4 40±7 39±3 
LV Ejection fraction (%) 67±5 71±8 69±4 
LV mass index (g/m2) 62±16† 64±13‡ 77±16 
IVS: interventricular septum thickness; PW: left ventricular (LV) posterior wall thickness; LVEDD:  
LV end-diastolic dimension; LVESD: LV end-systolic dimension; LAD: left atrial dimension;  
AoD: aortic root diameter; RVD:  right ventricular dimension 
*: p <0.01 vs. Controls  †: p <0.05 vs. Controls 
Comparisons of values between the study groups were performed with ANOVA followed by Student’s 
unpaired t-test. Proportional data were analyzed by the chi-square test, with Yates’ correction. 
Table 8. Comparative echocardiographic data among the study groups 
Reasonable potentiation of cerebrovascular flow without exaggerated activation or 
perturbation of autonomic nervous system may be needed for effective treatment. However, 
administration of nonselective vasoconstrictive agents may cause a simple reduction of 
cerebral blood flow via elevation of cerebrovascular resistance, although intravenous 
infusion of phenylephrine, a sympathetic nerve α1 stimulator, has been reported to improve 
OI, as a result of producing significant peripheral vasoconstriction and venoconstriction in 
some OI patients.56 Volume repletion by increasing sodium intake or by treatment with 
fludrocortisones may theoretically improve OI and also symptoms of CFS by replenishing 
intravascular volume.17,35,38,42,46 Military anti-shock trousers as well as elastic stockings 
which compress lower extremities may also be effective via potentiation of venous return, 
resulting in increased cardiac output.44 Although CFS patients are limited by the discomfort 
of an increased perception of exertion, there are some data to support the notion that an 
appropriately designed exercise program is beneficial.50,57-59 Various triggers including loss 
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of appetite, diarrhea and sweating can cause dehydration accompanied by preload 
reduction, leading to further decreases in stroke volume and cardiac output, thereby 
impairing both systemic and cerebral circulation and exacerbating symptoms, and therefore 
should be avoided or treated appropriately. 
 
Fig. 12. The putative mechanism by which orthostatic intolerance and chronic fatigue 
syndrome are triggered in patients with a small heart. 
4. Conclusions 
Cardiac dysfunction with low cardiac output due to a small LV chamber may contribute to 
the development of chronic fatigue as a constitutional factor in a considerable number of 
CFS patients and its degree appears to be more pronounced in CFS patients with OI.60 CFS 
with OI seems to constitute a well-defined and predominant subgroup of CFS. Small heart 
with reduced cardiac performance due to decreased preload may be an important target for 
the treatment of CFS.  
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